Introduction
Introduction

Adiponectin (ApN) is an adipose-specific secretory protein that acts as an anti-diabetic and anti-atherosclerotic molecule
.
Furthermore, a number of clinical trials have shown that subjects with high levels of circulating ApN tend to be protected against type 2 diabetes and myocardial infarction. Previous study reported that higher concentrations of ApN protected against later development of type 2 diabetes (incidence rate ratio 0·63; 95% confidence interval [CI] 0·43-0·92)
, P ϭ 0.02) [4] . Pischon et al. reported that participants in the highest compared with the lowest quintile of ApN levels had a significantly decreased risk of myocardial infarction (relative risk, 0.39; 95% CI, 0.23-0.64; P Ͻ 0.001) [5] . Several factors regulate ApN gene expression, including other adipocytokines such as tumour necrosis factor-␣ and IL-6 [1, 6] ; transcription factors such as peroxisome proliferator-activated receptor-␥ and liver receptor homolog-1 [7] ; CCAAT/enhancer-binding protein (C/EBP); nuclear transcription factor-Y (NF-Y); and sterol regulatory element-binding protein-1c [8] . A previous report showed that cAMP inhibited ApN gene expression in human visceral adipose tissue. Likewise, cAMP down-regulated ApN mRNAs in cultured mouse explants from visceral and subcutaneous regions [9] . The amount of ApN released into the medium decreased concomitantly; however, the underlying mechanism is not clear. [10, 11] . The 
The prolactin regulatory element-binding (PREB) gene encodes a 1.9-kb mRNA that translates into a transcription factor
Material and methods
Cell culture
In vitro transcription and translation
The pcDNA3.1 (ϩ) vector carrying PREB cDNA or solely vector was transcribed in vitro with T7 RNA polymerase (Gibco-BRL), as previously described [13] . The RNA product was translated with a rabbit reticulocyte lysate system (Promega, San Luis Obispo, CA). 
Immunohistochemical localization of PREB
Western blot analysis
Cells were washed, scraped into PBS and lysed, as described previously [15] . 
Transfection of 3T3-L1 cells and luciferase reporter gene assay
To confirm the transcriptional regulation of the ApN promoter by PREB, we used a plasmid construct containing the mouse ApN promoter obtained by PCR amplification, cloned in front of the luciferase reporter gene as previously described [8] . Wild type (Ϫ984 WT LUC) contains the mouse ApN gene sequences spanning the region from Ϫ984 to ϩ1, linked to the luciferase reporter gene [8] . The constructs, mutant types Ϫ984 mA1-LUC, Ϫ984 mA2-LUC and Ϫ984 mA3-LUC lack the consensus sequence A1, A2 and A3, respectively, and were generated as described previously [16] . Site 
Generation of adenovirus and adenovirus treatment
The full-length rat PREB cDNA was inserted into the pShattle vector plasmid, as previously described [10] .
Adenovirus expressing the PREB (Ad-PREB) was constructed according to the instructions for the Adeno-X Expression System kit (CLONTECH Laboratories, Palo Alto, CA). As a control, Adeno-X-lacZ adenovirus (Ad-LacZ) was generated. Adenoviruses were amplified in HEK 293 cells and purified and concentrated to 10 12 plaque-forming units per milllitre (pfu/ml) by CsCl ultracentrifugation. Expression of PREB was transduced by incubation with the Ad-PREB adenoviruses for 3 hrs at a multiplicity of infection of 1000 pfu/cells.
Transfection of siRNA
The siRNAs were designed to target the following cDNA sequences: scrambled, 5Ј-CCGTTCTGTACAGGGAGTACT-3Ј; and PREB siRNA, 5Ј-AATG-GCGTGCACTTTCTGCAG-3Ј [13] . Transfection of PREB siRNA was performed using siPORT Lipid (Ambion, Austin, TX), as described previously [16] . ApN protein expression was examined using Western blot analysis, 3 days after transfection. [13] . PREB repressed ApN promoter activity by 40% (P Ͻ 0.05) in COS-7 cells (Fig. 2A) (Fig. 3) (Fig. 4) . Results in Fig. 4 show that the presence of PREB reduced wild-type ApN promoter activity by 60% (P Ͻ 0.05); this reduction was dependent on the 
Experimental animals
Eight-week-old male C57BKS/J db/db mice (db/db) and their agematched control lean mice (lean) were purchased from The Jackson Laboratory (Bar harbor, ME). Protocol employed in this experiment
PREB suppressed the ApN promoter activity and protein expression in COS-7 cells
To determine whether PREB affected the transcriptional activity of the ApN promoter, we used the Ϫ984 WT LUC construct composed of a full-length mouse ApN promoter cotransfected into COS-7 cells with a PREB expression vector, because a Northern blot analysis of this cell line yielded undetectable levels of PREB
Fig. 1 Expression of PREB. (A) Tissue distribution of PREB in various mouse tissues. RT-PCR analysis of PREB transcripts in mouse tissues. ␤-actin was used as a control for equal RNA loading. Lane 1, maker; lane 2, adipose tissue; lane 3, liver; lane 4, kidney; lane 5, pancreas; lane 6, spleen. (B) The presence of PREB mRNA in mouse adipose tissue, undifferentiated and differentiated 3T3-L1 cells and INS-1 cells was examined by RT-PCR analysis of 3 g of poly-A RNA from these cells; ␤-actin was used as a control for equal RNA loading. Lane 1, marker; lane 2, water as a negative control; lane 3, INS-1; lane 4, undifferentiated 3T3-L1; lane 5, differentiated 3T3-L1; lane 6, adipose tissue. (C) Immunohistochemical localization of PREB in human adipose tissue. Immunoperoxidase staining of PREB was presented in the nuclear of human adipose tissue (II), and the tissue stained with control serum was negative (I). (D) PREB protein expression. Nuclear extract from differentiated 3T3-L1 cells was subjected to Western blot analysis. Abundance of ␤-tubulin served as a control and was found at the bottom of each lane. Lane 1, undifferentiated 3T3-L1 nuclear extract; lane 2, differentiated 3T3-L1 nuclear extract. The ratio of adiponectin to ␤-tubulin is shown as a percentage of control. Each data point shows the mean Ϯ S.E. (n ϭ 3) of separate experiments. The asterisk denotes a significant difference (P Ͻ 0.01).
Fig. 2 The role of PREB in the regulation of adiponectin expression in COS-7 cells. (A) Dishes (60 mm) of COS-7 cells were cotransfected with 1 g of -984 WT-LUC plus the indicated amounts of PREB expression
Fig. 3 Effects of cAMP on PREB protein accumulation in 3T3-L1 cells. Protein extract of differentiated 3T3-L1 cells treated with varying concentrations of cAMP for 24 hrs. Western blot analysis was performed to examine PREB accumulation (upper panel). Analysis of GAPDH as a control is shown at the bottom of each lane. The ratio of PREB to GAPDH is shown as the percentage of control (lower panel). Each data point shows the mean Ϯ S.E. (n ϭ 3) of separate experiments. The asterisk denotes a significant difference (P Ͻ 0.05). amount of PREB. The results showed that PREB had no effect on A1-mutated ApN promoter activity, but it still had effects on the A2 and A3 mutants (Fig. 4). These findings suggest that the A1 element is required for the actions of PREB on ApN promoter activity. To determine whether the binding activity to the A1 motif was indeed due to the PREB, we synthesized the PREB protein using in vitro transcription/translation. The product arising from this approach yielded a major single band with a mass of 45 kD, as determined using Western blot analysis (data not shown).
Whether the in vitro synthesized PREB could bind the radiolabelled A1 motif was studied using EMSA. Results showed that PREB expressed using in vitro transcription/translation bound to A1 element (Fig. 5A) . PREB binds directly to site 1P of the prolactin promoter [10] . We used an EMSA competition analysis of PREB binding to the 1P site in the presence of a 50-or 200-fold molar excess of unlabelled A1 element competitor DNA. Results (Fig. 5B) show that the nuclear extract from the 3T3-L1 cells were bound to 1P. The addition of excess A1 element DNA competed for PREB binding to the radio-labelled 1P probe. To confirm that PREB bound to the A1 element directory, we employed the super shift assay with a specific antiserum against PREB.
Our results (Fig. 3B and C) show that the protein-DNA complex was shifted by the addition of anti-PREB antiserum but not by pre-immune serum. (Fig. 6B) . [4, 20] . ApN increases the insulin sensitivity associated with the activation of insulin signalling and glucose uptake [21] ; furthermore, the administration of full-length ApN lowers plasma glucose levels by suppressing hepatic glucose production in obese and diabetic mice [3] . 
PREB knock-down or site-directed mutagenesis of the A1 abrogates the effect of cAMP
